Medtronic (NYSE:MDT) Coverage Initiated at Leerink Partners
Equities research analysts at Leerink Partners started coverage on shares of Medtronic (NYSE:MDT – Get Free Report) in a research report issued on Monday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $110.00 price target on the medical technology company’s stock. Leerink Partners’ price objective would suggest a potential upside of 27.63% […]
